Monkeypox Vaccine and Treatment Market Size, Share, By Product Type (Vaccine (JYNNEOS/ Imvanex, Smallpox Vaccine, Others), Drugs (Tecovirimat, Brincidofovir, Cidofovir, Others), and Vaccinia Immune Globulin), By Gender Type (Male, Female, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others (Government agencies)), and By Region - Trends, Analysis and Forecast till 2034

Next-generation vaccine platforms:

• The development of successful mRNA vaccines for COVID-19 showed that these next-generation platforms may be tailored for addressing other infectious diseases, such as monkeypox. Investment in these technologies would mean the creation of better, more scalable vaccines. Companies using this development by focusing on mRNA, viral vectors, and other new platform technologies can develop vaccines that hold more potential to create higher coverage with less dosing—precisely the kind of innovation that can open up new markets and stimulate demand for high-tech offerings in vaccine solutions.